Reimagining Diagnostics
From the laboratory to the clinician to the patient, discover how we’re powering the moments that matter.
From the laboratory to the clinician to the patient, discover how we’re powering the moments that matter.
Our impact spans from lab to life, speeding the translation of advanced science to real-world impact and improving the lives of millions of patients globally.
Guided by our culture of continuous improvement, we’re turning scientific potential into progress and helping providers deliver accurate answers sooner —because time saves lives, and speed with certainty matters.
At Danaher we unite diagnostics, life sciences, and biotech to deliver faster, smarter solutions—because lives depend on it.
The impact of our industry-leading businesses - Beckman Coulter Diagnostics, Beckman Coulter Life Sciences, Cepheid, Cytiva, HemoCue, Leica Biosystems, Radiometer and SCIEX – spans from lab to life, speeding the translation of advanced science to real-world impact by:
• Delivering faster, more reliable answers to help providers make confident decisions, improve treatment options and save lives
• Collaborating to discover new biomarkers and develop high-resolution tools to unlock breakthroughs that transform patient care
• Expanding access to diagnostics and therapeutics for millions of patients, leveraging our global scale and operational expertise to improve human health
Request appointment
Through expertise and strategic partnerships, we are pushing boundaries with next-generation technologies that improve workflow and drive confidence in patient results. From innovative biomarkers to workflow automation, here are just a few of the solutions that will be on display at ADLM.
Advantaged Workflows
Accelerate more precise clinical decision-making—from sample collection to diagnostic insight—unlocking the power of every sample and improving workflow to create new value for your laboratory teams.
Learn more
Digital Hematology
Discover how we’re delivering more insights from the CBC so you can support a higher standard of care with a growing menu of advanced biomarkers and unparalleled clinical sensitivity.
Learn more
High-Sensitivity Diagnostics
Revolutionize your core lab’s impact with unprecedented high-sensitivity diagnostic testing across diverse areas like cardiovascular disease, infectious disease, and women’s health.
Learn more

Catch up with these educational resources shared at ADLM 2024.
Tell us you're coming and we'll connect you with a member of the Beckman Coulter team for a tailored demo of the solutions that matter to you.
Complete the form below and we’ll reach out soon.
Thank you for your request.
A Beckman Coulter representative will contact you shortly.
Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.
© 2026 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners. Some products may not be available in your country or region. Please contact your Beckman Coulter sales representative or distributor for more information.
U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.


